US-based company Arbiter has emerged from stealth, raising $52m in funding to address healthcare fragmentation by connecting patients, providers, and payers through an AI-powered care orchestration platform.

The financing round, led by MFO Ventures and TriEdge Investments alongside private equity company WindRose Health Investors, values the company at $400m.

The company noted that delivery of effective patient care relies on coordination, however, patients, providers, and payers presently function in isolation.

Arbiter addresses this issue by integrating technology, data, and stakeholders to bridge care gaps and facilitate further actions, beginning with real-time site-of-care optimisation.

The company’s care platform links the systems and individuals involved in every care decision, ensuring patients transition smoothly from detection to resolution without unnecessary delays.

It is based on Arbiter's Record-Action-Alignment model, which consolidates financial, policy, and clinical data into a comprehensive, longitudinal patient record.

The company's inaugural application, real-time site-of-care optimisation, functions through collaborations with a national provider and payer networks.

Over time, Arbiter aims to develop its AI from reactive problem-solving to proactive management that anticipates patient requirements and employs predictive intelligence to forecast system-wide risks, disease onset, and hospital utilisation.

Arbiter co-founder and CEO Michelle Carnahan said: “Arbiter's mission is nothing less than to rebuild the operating spine of US healthcare. By aligning payers and providers around the needs of patients, we're transforming healthcare from a fragmented set of parts into a connected system that works for everyone.”

It is developed and financed by executives managing more than $25bn in annual healthcare payments and serving several patients.